Rapport
Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm - update 15 March 2022
Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm
Auteurs
Langues
- Anglais
Année de publication
2021
Type
Rapport
Catégories
- Vaccins et dispositifs d'administration
Maladies
- COVID-19
Pays
- Chine
Mots-clés
- Introduction de nouveaux vaccins
